Physician profile
Ernestine A Wright
NPI 1306896006
$1,259.33
in general payments reported to CMS, 2019-2025
18 companies · $667 in 2025
The $667 reported for 2025 was more than what 83% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $73.97 · 2021: $21.07 · 2023: $93.76 · 2024: $66.71 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.06 |
| Education | $117.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $292.79 | 2019-2025 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $157.95 | 2024-2025 | Veozah |
| Glaxosmithkline, LLC. | $143.59 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $127.78 | 2025 | |
| Pfizer INC. | $78.64 | 2019-2025 | |
| Allergan, INC. | $74.07 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $70.84 | 2025 | Farxiga, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $69.12 | 2019 | |
| Lilly USA, LLC | $52.39 | 2020-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $42.45 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $30.48 | 2019 | |
| Daiichi Sankyo INC. | $24.52 | 2020 | |
| Abbvie INC. | $22.96 | 2023 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.24 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.46 | 2019 | |
| Phathom Pharmaceuticals, INC. | $13.12 | 2025 | Voquezna |
| Nabriva Therapeutics, Plc | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernestine Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.